$Novo Nordisk AS(NVO.US) Some perspectives on Alzheimer's disease: Alzheimer's disease is considered a brain-specific insulin resistance and insulin signaling disorder, which can be viewed as "diabetes" of the central nervous system. When brain cells develop insulin resistance, phenomena such as β-amyloid deposition, tau protein hyperphosphorylation, inflammation, and synaptic dysfunction occur—all typical pathological features of Alzheimer's. Additionally, obesity and diabetes show a positive correlation with the increasing proportion of Alzheimer's patients. Perhaps weight-loss drugs could treat Alzheimer's in the future. 🧐